Pederson RA - Search Results

1

Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus.

McIntosh CH, Demuth HU, Kim SJ, Pospisilik JA, Pederson RA. McIntosh CH, et al. Among authors: pederson ra. Int J Biochem Cell Biol. 2006;38(5-6):860-72. doi: 10.1016/j.biocel.2005.12.013. Epub 2006 Jan 11. Int J Biochem Cell Biol. 2006. PMID: 16442340 Review.

2

Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?

McIntosh CH, Demuth HU, Pospisilik JA, Pederson R. McIntosh CH, et al. Regul Pept. 2005 Jun 15;128(2):159-65. doi: 10.1016/j.regpep.2004.06.001. Regul Pept. 2005. PMID: 15780435 Review.

3

Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats.

Hinke SA, Gelling RW, Pederson RA, Manhart S, Nian C, Demuth HU, McIntosh CH. Hinke SA, et al. Among authors: pederson ra. Diabetes. 2002 Mar;51(3):652-61. doi: 10.2337/diabetes.51.3.652. Diabetes. 2002. PMID: 11872663

4

Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.

Pospisilik JA, Stafford SG, Demuth HU, McIntosh CH, Pederson RA. Pospisilik JA, et al. Among authors: pederson ra. Diabetes. 2002 Sep;51(9):2677-83. doi: 10.2337/diabetes.51.9.2677. Diabetes. 2002. PMID: 12196458

5

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.

Pamir N, Lynn FC, Buchan AM, Ehses J, Hinke SA, Pospisilik JA, Miyawaki K, Yamada Y, Seino Y, McIntosh CH, Pederson RA. Pamir N, et al. Among authors: pederson ra. Am J Physiol Endocrinol Metab. 2003 May;284(5):E931-9. doi: 10.1152/ajpendo.00270.2002. Epub 2003 Jan 21. Am J Physiol Endocrinol Metab. 2003. PMID: 12540373 Free article.

6

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, Pederson RA. Pospisilik JA, et al. Among authors: pederson ra. Diabetes. 2003 Mar;52(3):741-50. doi: 10.2337/diabetes.52.3.741. Diabetes. 2003. PMID: 12606516

7

Dipeptidyl peptidase IV inhibition in animal models of diabetes.

Pospisilik JA, Ehses JA, Doty T, McIntosh CH, Demuth HU, Pederson RA. Pospisilik JA, et al. Among authors: pederson ra. Adv Exp Med Biol. 2003;524:281-91. doi: 10.1007/0-306-47920-6_34. Adv Exp Med Biol. 2003. PMID: 12675250 No abstract available.

8

Glucose-dependent insulinotropic polypeptide (GIP): development of DP IV-resistant analogues with therapeutic potential.

Hinke SA, Lynn F, Ehses J, Pamir N, Manhart S, Kühn-Wache K, Rosche F, Demuth HU, Pederson RA, McIntosh CH. Hinke SA, et al. Among authors: pederson ra. Adv Exp Med Biol. 2003;524:293-301. doi: 10.1007/0-306-47920-6_35. Adv Exp Med Biol. 2003. PMID: 12675251 No abstract available.

9

[Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo.

Hinke SA, Manhart S, Kühn-Wache K, Nian C, Demuth HU, Pederson RA, McIntosh CH. Hinke SA, et al. Among authors: pederson ra. J Biol Chem. 2004 Feb 6;279(6):3998-4006. doi: 10.1074/jbc.M311304200. Epub 2003 Nov 10. J Biol Chem. 2004. PMID: 14610075 Free article.

10

In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide.

Hinke SA, Manhart S, Speck M, Pederson RA, Demuth HU, McIntosh CH. Hinke SA, et al. Among authors: pederson ra. Life Sci. 2004 Aug 27;75(15):1857-70. doi: 10.1016/j.lfs.2004.03.024. Life Sci. 2004. PMID: 15302229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page